Kazia Therapeutics (KZIA) Non-Current Assets (2017 - 2025)

Kazia Therapeutics (KZIA) has disclosed Non-Current Assets for 6 consecutive years, with $721768.2 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Non-Current Assets fell 92.91% year-over-year to $721768.2, compared with a TTM value of $721768.2 through Jun 2025, down 92.91%, and an annual FY2025 reading of $730441.7, down 92.79% over the prior year.
  • Non-Current Assets was $721768.2 for Q2 2025 at Kazia Therapeutics, down from $10.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $18.9 million in Q2 2022 and bottomed at $721768.2 in Q2 2025.
  • Average Non-Current Assets over 4 years is $10.4 million, with a median of $10.9 million recorded in 2024.
  • The sharpest move saw Non-Current Assets fell 12.06% in 2024, then plummeted 92.91% in 2025.
  • Year by year, Non-Current Assets stood at $18.9 million in 2022, then plummeted by 38.9% to $11.6 million in 2023, then fell by 12.06% to $10.2 million in 2024, then tumbled by 92.91% to $721768.2 in 2025.
  • Business Quant data shows Non-Current Assets for KZIA at $721768.2 in Q2 2025, $10.2 million in Q2 2024, and $11.6 million in Q2 2023.